Edible electronics to treat the brain
Assistant Professor Khalil Ramadi’s essay on the potential of ingestible electroceuticals to treat diseases was named a finalist in The BioInnovation Institute & Science Prize for Innovation. “My goal is to develop an entirely new class of medical therapy: ingestible electroceuticals for neuromodulation. Such an approach could be as noninvasive as oral medications yet as targeted as implanted neural DBS probes. I hope to leverage ingestible electroceuticals for neuromodulation in metabolic, gastrointestinal, and digestive disorders,” wrote Ramadi.
Researchers
Khalil Ramadi
Assistant Professor of Bioengineering
